Use of aspartame in phenylketonuric heteroxygous adults.
Asparatame, a new artificial sweetener, was administered to 45 obligate phenylketonuric adults for 28 wk. This new sweetening agent was well tolerated, and no untoward medical or biochemical changes were noted.
D000328:Adult; D001218:Aspartame / Q000009:adverse effects / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004151:Dipeptides / Q000494:pharmacology*; D005260:Female; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D010649:Phenylalanine / Q000097:blood; D010661:Phenylketonurias / Q000097:blood*; D010919:Placebos; D014443:Tyrosine / Q000097:blood
D004151:Dipeptides; D010919:Placebos; D014443:Tyrosine; D010649:Phenylalanine; D001218:Aspartame